Kathy Wolski

24.9k total citations · 11 hit papers
111 papers, 16.5k citations indexed

About

Kathy Wolski is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kathy Wolski has authored 111 papers receiving a total of 16.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Surgery, 50 papers in Cardiology and Cardiovascular Medicine and 22 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kathy Wolski's work include Coronary Interventions and Diagnostics (24 papers), Lipoproteins and Cardiovascular Health (20 papers) and Antiplatelet Therapy and Cardiovascular Diseases (18 papers). Kathy Wolski is often cited by papers focused on Coronary Interventions and Diagnostics (24 papers), Lipoproteins and Cardiovascular Health (20 papers) and Antiplatelet Therapy and Cardiovascular Diseases (18 papers). Kathy Wolski collaborates with scholars based in United States, Australia and Netherlands. Kathy Wolski's co-authors include Steven E. Nissen, Philip R. Schauer, Stacy A. Brethauer, Deepak L. Bhatt, Stephen J. Nicholls, Sangeeta R. Kashyap, John P. Kirwan, Claire E. Pothier, A. Michael Lincoff and Ali Aminian and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Kathy Wolski

110 papers receiving 15.9k citations

Hit Papers

Effect of Rosiglitazone o... 2007 2026 2013 2019 2007 2017 2012 2014 2007 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
    2007 3.5k citations Steven E. Nissen, Kathy Wolski profile →
  2. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
    2017 1.8k citations Philip R. Schauer, Deepak L. Bhatt et al. profile →
  3. Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
    2012 1.5k citations Philip R. Schauer, Sangeeta R. Kashyap et al. profile →
  4. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
    2014 1.4k citations Philip R. Schauer, Deepak L. Bhatt et al. profile →
  5. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.
    2007 961 citations A. Michael Lincoff, Kathy Wolski et al. PubMed profile →
  6. Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
    2008 664 citations Steven E. Nissen, Stephen J. Nicholls et al. JAMA profile →
  7. Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis
    2007 543 citations Stephen J. Nicholls, E. Murat Tuzcu et al. JAMA profile →
  8. Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity
    2019 306 citations Ali Aminian, Alexander Zajichek et al. JAMA profile →
  9. Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection
    2021 240 citations Kathy Wolski, Qiuqing Wang et al. profile →
  10. Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
    2022 183 citations Milind Y. Desai, Anjali Owens et al. Journal of the American College of Cardiology profile →
  11. Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a)
    2024 43 citations Steven E. Nissen, Kathy Wolski et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathy Wolski United States 47 8.7k 6.1k 3.9k 3.5k 3.5k 111 16.5k
Helen M. Colhoun United Kingdom 65 8.0k 0.9× 8.8k 1.4× 1.6k 0.4× 4.2k 1.2× 2.3k 0.7× 278 19.3k
Robert E. Ratner United States 60 5.1k 0.6× 10.7k 1.8× 1.8k 0.5× 2.0k 0.6× 3.7k 1.0× 159 16.6k
Jeffrey I. Mechanick United States 50 5.7k 0.7× 6.2k 1.0× 2.8k 0.7× 1.3k 0.4× 1.5k 0.4× 233 13.3k
Harold Bays United States 71 10.0k 1.2× 7.2k 1.2× 3.4k 0.9× 3.4k 1.0× 2.2k 0.6× 356 19.0k
Irene Stratton United Kingdom 47 4.7k 0.5× 16.3k 2.7× 2.2k 0.6× 3.8k 1.1× 3.7k 1.0× 142 24.5k
Itamar Raz Israel 67 5.6k 0.6× 15.2k 2.5× 3.3k 0.9× 6.4k 1.8× 6.1k 1.7× 374 26.0k
H. A. W. Neil United Kingdom 47 6.5k 0.7× 10.3k 1.7× 1.4k 0.4× 3.3k 0.9× 2.6k 0.7× 113 17.4k
H Bryan Brewer United States 58 9.8k 1.1× 8.3k 1.4× 2.4k 0.6× 4.6k 1.3× 5.2k 1.5× 152 21.8k
Ildiko Lingvay United States 52 3.8k 0.4× 11.2k 1.8× 3.3k 0.9× 1.8k 0.5× 5.2k 1.5× 220 15.6k
Janet B. McGill United States 64 3.4k 0.4× 9.1k 1.5× 1.6k 0.4× 3.0k 0.8× 2.4k 0.7× 236 16.2k

Countries citing papers authored by Kathy Wolski

Since Specialization
Citations

This map shows the geographic impact of Kathy Wolski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Wolski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Wolski more than expected).

Fields of papers citing papers by Kathy Wolski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Wolski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Wolski. The network helps show where Kathy Wolski may publish in the future.

Co-authorship network of co-authors of Kathy Wolski

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Wolski. A scholar is included among the top collaborators of Kathy Wolski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Wolski. Kathy Wolski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nissen, Steven E., Kathy Wolski, Gerald F. Watts, et al.. (2024). Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a). JAMA. 331(18). 1534–1534. 43 indexed citations breakdown →
2.
Desai, Milind Y., Kathy Wolski, Anjali Owens, et al.. (2024). Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM. Circulation. 151(19). 1378–1390. 14 indexed citations
3.
Cremer, Paul, Jeffrey B. Geske, Anjali Owens, et al.. (2022). Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study. Circulation Cardiovascular Imaging. 15(12). e014986–e014986. 41 indexed citations
4.
Kirwan, John P., Anita P. Courcoulas, David E. Cummings, et al.. (2022). Diabetes Remission in the Alliance of Randomized Trials of Medicine Versus Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D). Diabetes Care. 45(7). 1574–1583. 69 indexed citations
5.
Desai, Milind Y., Anjali Owens, Jeffrey B. Geske, et al.. (2022). Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks. Circulation. 147(11). 850–863. 53 indexed citations
6.
Aminian, Ali, Rickesha Wilson, Alexander Zajichek, et al.. (2021). Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care. Diabetes Care. 44(11). 2552–2563. 41 indexed citations
7.
Wang, Qiuqing, Dmitry Yaranov, Kathy Wolski, et al.. (2021). Dynamic Assessment of Pulmonary Artery Pulsatility Index Provides Incremental Risk Assessment for Early Right Ventricular Failure After Left Ventricular Assist Device. Journal of Cardiac Failure. 27(7). 777–785. 21 indexed citations
8.
Solomon, Daniel H., Ming Shao, Kathy Wolski, et al.. (2019). Derivation and Validation of a Major Toxicity Risk Score Among Nonsteroidal Antiinflammatory Drug Users Based on Data From a Randomized Controlled Trial. Arthritis & Rheumatology. 71(8). 1225–1231. 11 indexed citations
9.
Aminian, Ali, Alexander Zajichek, David Arterburn, et al.. (2019). Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity. JAMA. 322(13). 1271–1271. 306 indexed citations breakdown →
10.
Yeomans, Neville D., David Y. Graham, M. Elaine Husni, et al.. (2018). Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial. Alimentary Pharmacology & Therapeutics. 47(11). 1453–1463. 35 indexed citations
11.
Reed, Grant W., Mouin Abdallah, Mingyuan Shao, et al.. (2017). Abstract 17856: Effect of Aspirin on the Cardiovascular, Gastrointestinal, and Renal Safety of Celecoxib, Naproxen, or Ibuprofen. Circulation. 1 indexed citations
12.
Nicholls, Stephen J., Allan Gordon, Jan Johansson, et al.. (2011). Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease. Journal of the American College of Cardiology. 57(9). 1111–1119. 134 indexed citations
13.
Hussein, Ayman A., Kiyoko Uno, Kathy Wolski, et al.. (2011). Peripheral Arterial Disease and Progression of Coronary Atherosclerosis. Journal of the American College of Cardiology. 57(10). 1220–1225. 72 indexed citations
14.
Bangalore, Sripal, Deepak L. Bhatt, Joachim Röther, et al.. (2010). Late Outcomes After Carotid Artery Stenting Versus Carotid Endarterectomy. Circulation. 122(11). 1091–1100. 20 indexed citations
15.
Hussein, Ayman A., Murat Tuzcu, Amy T. Hsu, et al.. (2010). Abstract 13442: Aging, Risk Factors and Progression of Coronary Atherosclerosis. Circulation. 122. 1 indexed citations
16.
Nissen, Steven E., Stephen J. Nicholls, Kathy Wolski, et al.. (2008). Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes. JAMA. 299(13). 1561–1561. 664 indexed citations breakdown →
17.
Schoenhagen, Paul, E. Murat Tuzcu, Carolyn Apperson-Hansen, et al.. (2006). Determinants of Arterial Wall Remodeling During Lipid-Lowering Therapy. Circulation. 113(24). 2826–2834. 105 indexed citations
18.
DesJardin, Lucy E., Mark D. Perkins, Kathy Wolski, et al.. (1999). Measurement of Sputum Mycobacterium tuberculosis Messenger RNA as a Surrogate for Response to Chemotherapy. American Journal of Respiratory and Critical Care Medicine. 160(1). 203–210. 91 indexed citations
19.
DesJardin, Lucy E., Mark D. Perkins, Kathy Wolski, et al.. (1999). Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy. 67. 10 indexed citations
20.
Johnson, John L., M. Vjecha, Kathy Wolski, et al.. (1998). Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration.. PubMed. 2(5). 397–404. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen M. Colhoun Breakdown of academic impact, for papers by Robert E. Ratner Breakdown of academic impact, for papers by Jeffrey I. Mechanick Breakdown of academic impact, for papers by Harold Bays Breakdown of academic impact, for papers by Irene Stratton Breakdown of academic impact, for papers by Itamar Raz Breakdown of academic impact, for papers by H. A. W. Neil Breakdown of academic impact, for papers by H Bryan Brewer Breakdown of academic impact, for papers by Ildiko Lingvay Breakdown of academic impact, for papers by Janet B. McGill
Rankless by CCL
2026